The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathologic indicators of chemotherapy response in colorectal liver metastases: A comparative study.
J. Maresch
No relevant relationships to disclose
S. Stremitzer
No relevant relationships to disclose
D. Tamandl
No relevant relationships to disclose
F. Wrba
No relevant relationships to disclose
T. Gruenberger
Consultant or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Honoraria - Amgen; Merck Serono; Pfizer; Roche; Sanofi
Research Funding - Amgen; Merck Serono; Pfizer; Roche; Sanofi